West Pharmaceutical Services, Inc. (WST) is a publicly traded Healthcare sector company. As of May 20, 2026, WST trades at $308.48 with a market cap of $21.51B and a P/E ratio of 40.45. WST moved +0.46% today. Year to date, WST is +9.49%; over the trailing twelve months it is +41.81%. Its 52-week range spans $187.43 to $352.33. Analyst consensus is buy with an average price target of $347.50. Rallies surfaces WST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
WST financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. WST recently traded at $308.48. Market cap is $21.51B. P/E ratio is 40.45. Revenue is $3.22B.
| Metric | Value |
|---|---|
| Price | $308.48 |
| Market Cap | $21.51B |
| P/E Ratio | 40.45 |
| EPS | $7.52 |
| Dividend Yield | 0.22% |
| 52-Week High | $352.33 |
| 52-Week Low | $187.43 |
| Volume | 403.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.22B |
| Net Income | $542.70M |
| Gross Margin | 36.28% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.07B | $493.70M | $6.83 |
| 2024 | $2.89B | $492.70M | $6.75 |
| 2023 | $2.95B | $593.40M | $7.98 |
| 2022 | $2.89B | $585.90M | $7.87 |
7 analysts cover WST: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $347.50.